| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Crinetics Pharmaceuticals, Inc. (CRNX) has 11 insiders with recent SEC Form 4 filings, including 8 buys and 7 sells. CRNX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 223.2K | $18.73M | - | |
| Other | 147.7K | $12.40M | - | |
| COO | 121.9K | $10.23M | - | |
| CFO | 84.8K | $7.12M | - | |
| Other | 69.0K | $5.79M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 20, 2019 | Vivo Capital Viii, LLC57 | 10% Owner | Sell | 417,000 | $22.25 | $9,278,250.00 | -11.2% | |
| Mar 18, 2019 | 5am Ventures Iv, L.P. | 10% Owner | Sell | 154,839 | $24.25 | $3,754,954.14 | -5.6% | |
| Jan 22, 2019 | 5am Ventures Iv, L.P. | 10% Owner | Sell | 262,153 | $21.88 | $5,734,596.88 | -7.5% | |
| Jul 20, 2018 | Perceptive Advisors LLC51 | Director, 10% Owner | Buy | 400,000 | $17.00 | $6,800,000.00 | +21.3% | |
| Jul 20, 2018 | Krasner Alan Seth | Chief Medical Officer | Buy | 2,000 | $17.00 | $34,000.00 | New | |
| Jul 20, 2018 | 5am Ventures Iv, L.P. | 10% Owner | Buy | 115,000 | $17.00 | $1,955,000.00 | +3.4% | |
| Jul 20, 2018 | Vivo Capital Viii, LLC57 | 10% Owner | Buy | 353,180 | $18.62 | $6,575,421.40 | +10.0% |